先声药业(02096.HK) 公布2024年度业绩,收入66.35亿人民币(下同),按年微增0.4%。录得纯利7.33亿元,增长2.6%,每股盈利29分。末期息维持派16分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-24 16:25。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/08/21 | 中期业绩 | 无派息 |
2024/03/20 | 末期业绩 | 股息:人民币 0.1600 (约相等于 0.1757 港元) |
2023/08/21 | 中期业绩 | 无派息 |
2023/03/31 | 末期业绩 | 股息:人民币 0.1600 (约相等于 0.17576 港元) |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.